Skip Nav Destination
Ofatumumab in diffuse large B cell lymphoma?
Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma
Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children’s Oncology Group
Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study
Long-term decline in intelligence among adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiation
Issue Archive
July 25 2013
Table of Contents
INSIDE BLOOD
CLINICAL TRIALS & OBSERVATIONS
Ofatumumab in diffuse large B cell lymphoma?
Clinical Trials & Observations
BLOOD WORK
PLENARY PAPER
BLOOD SPOTLIGHT
REVIEW ARTICLE
CLINICAL TRIALS AND OBSERVATIONS
Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma
Clinical Trials & Observations
Matthew J. Matasar,Myron S. Czuczman,Maria Alma Rodriguez,Michael Fennessy,Thomas C. Shea,Gary Spitzer,Izidore S. Lossos,Mohamed A. Kharfan-Dabaja,Robin Joyce,Luis Fayad,Kristen Henkel,Qiming Liao,Klaus Edvardsen,Roxanne C. Jewell,Doug Fecteau,Rajendra P. Singh,Steen Lisby,Craig H. Moskowitz
Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children’s Oncology Group
Clinical Trials & Observations
Wanda L. Salzer,Barbara Asselin,Jeffrey G. Supko,Meenakshi Devidas,Nicole A. Kaiser,Paul Plourde,Naomi J. Winick,Gregory H. Reaman,Elizabeth Raetz,William L. Carroll,Stephen P. Hunger
Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study
Clinical Trials & Observations
David M. Ross,Susan Branford,John F. Seymour,Anthony P. Schwarer,Christopher Arthur,David T. Yeung,Phuong Dang,Jarrad M. Goyne,Cassandra Slader,Robin J. Filshie,Anthony K. Mills,Junia V. Melo,Deborah L. White,Andrew P. Grigg,Timothy P. Hughes
HEMATOPOIESIS AND STEM CELLS
IMMUNOBIOLOGY
LYMPHOID NEOPLASIA
Long-term decline in intelligence among adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiation
Brief Report
Kevin R. Krull,Nan Zhang,Aimee Santucci,Deo Kumar Srivastava,Matthew J. Krasin,Larry E. Kun,Ching-Hon Pui,Leslie L. Robison,Melissa M. Hudson,Gregory T. Armstrong
MYELOID NEOPLASIA
Exome sequencing identifies putative drivers of progression of transient myeloproliferative disorder to AMKL in infants with Down syndrome
Sergey I. Nikolaev,Federico Santoni,Anne Vannier,Emilie Falconnet,Emanuela Giarin,Giuseppe Basso,Alexander Hoischen,Joris A. Veltman,Jurgen Groet,Dean Nizetic,Stylianos E. Antonarakis
PLATELETS AND THROMBOPOIESIS
THROMBOSIS AND HEMOSTASIS
Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project
Jill M. Johnsen,Paul L. Auer,Alanna C. Morrison,Shuo Jiao,Peng Wei,Jeffrey Haessler,Keolu Fox,Sean R. McGee,Joshua D. Smith,Christopher S. Carlson,Nicholas Smith,Eric Boerwinkle,Charles Kooperberg,Deborah A. Nickerson,Stephen S. Rich,David Green,Ulrike Peters,Mary Cushman,Alex P. Reiner,on behalf of the NHLBI Exome Sequencing Project,on behalf of the NHLBI Exome Sequencing Project,on behalf of the NHLBI Exome Sequencing Project,on behalf of the NHLBI Exome Sequencing Project,on behalf of the NHLBI Exome Sequencing Project,on behalf of the NHLBI Exome Sequencing Project,on behalf of the NHLBI Exome Sequencing Project,on behalf of the NHLBI Exome Sequencing Project,on behalf of the NHLBI Exome Sequencing Project,on behalf of the NHLBI Exome Sequencing Project,on behalf of the NHLBI Exome Sequencing Project,on behalf of the NHLBI Exome Sequencing Project,on behalf of the NHLBI Exome Sequencing Project,on behalf of the NHLBI Exome Sequencing Project,on behalf of the NHLBI Exome Sequencing Project,on behalf of the NHLBI Exome Sequencing Project,on behalf of the NHLBI Exome Sequencing Project,on behalf of the NHLBI Exome Sequencing Project,on behalf of the NHLBI Exome Sequencing Project
VASCULAR BIOLOGY
-
Cover Image
Cover Image
![issue cover]()
The authors demonstrate that the E3 ubiquitin ligase ASB2α, through degradation of its substrate filamins, acts as a positive regulator of podosome rosette formation, extracellular matrix degradation, and subsequent migration of immature dendritic cells. The cover image shows bone marrow-derived dendritic cells that were stained with antibodies to filamin A (green), vinculin (red), and phalloidin (blue). See the article by Lamsoul et al on page 533.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals
